✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Lactose (India) Ltd.

LACTOSE

Market Cap
₹133 Cr.
P/E
27.55

Lactose (India) Ltd.

  • Lactose India
  • Accretion Pharma.
  • Smruthi Organics

FAQs on Lactose (India) Ltd. Shareprice

Lactose India has given better returns compared to its competitors.
Lactose India has grown at ~2.16% over the last 10yrs while peers have grown at a median rate of -2.0%

Lactose India is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Lactose India is 28.37, while 3 year average PE is 49.51.
Also latest EV/EBITDA of Lactose India is 11.47 while 3yr average is 10.61.

View FAQ's On Business

Growth Table

  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Balance Sheet

  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Cash Flow

  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Quarterly Results

  • Lactose (India) Ltd.
  • Accretion Pharma.
  • Smruthi Organics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Lactose (India) Ltd. Financials

Balance sheet of Lactose India is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Lactose India is increasing.
Latest net debt of Lactose India is ₹48.78 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹46.4 Crs.

No, profit is decreasing.
The profit of Lactose India is ₹4.83 Crs for TTM, ₹5.16 Crs for Mar 2025 and ₹6.79 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lactose India latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech